Patents by Inventor Geula Hanin

Geula Hanin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOWNREGULATING MIR-132 FOR THE TREATMENT OF LIPID RELATED DISORDERS
    Publication number: 20190078090
    Abstract: A method of treating a lipid-related disorder in a subject in need thereof is disclosed. The method comprises administering to the subject a therapeutically effective amount of a polynucleotide agent which is substantially complementary to a nucleotide sequence of human miR-132, thereby treating the lipid related disorder in the subject.
    Type: Application
    Filed: November 19, 2018
    Publication date: March 14, 2019
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Hermona SOREQ, Geula HANIN, David S. GREENBERG
  • Downregulating miR-132 for the treatment of lipid related disorders
    Patent number: 10174320
    Abstract: A method of treating a lipid-related disorder in a subject in need thereof is disclosed. The method comprises administering to the subject a therapeutically effective amount of a polynucleotide agent which is substantially complementary to a nucleotide sequence of human miR-132, thereby treating the lipid related disorder in the subject.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: January 8, 2019
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Hermona Soreq, Geula Hanin, David S. Greenberg
  • DOWNREGULATING MIR-132 FOR THE TREATMENT OF LIPID RELATED DISORDERS
    Publication number: 20170283800
    Abstract: A method of treating a lipid-related disorder in a subject in need thereof is disclosed. The method comprises administering to the subject a therapeutically effective amount of a polynucleotide agent which is substantially complementary to a nucleotide sequence of human miR-132, thereby treating the lipid related disorder in the subject.
    Type: Application
    Filed: September 21, 2015
    Publication date: October 5, 2017
    Inventors: Hermona SOREQ, Geula HANIN, David S. GREENBERG
  • CLUSTERED SINGLE NUCLEOTIDE POLYMORPHISMS IN THE HUMAN ACETYLCHOLINESTERASE GENE AND USES THEREOF IN DIAGNOSIS AND THERAPY
    Publication number: 20150119447
    Abstract: The present invention relates to diagnostic and prognostic methods and kits for determining genetic predisposition for at least one AChE-associated disorder, as well for diagnosing, prognosing and monitoring said disorders. The methods of the invention are based on detection of specific SNPs that modulate the interaction of different miRNAs to AChE 3?-UTR.
    Type: Application
    Filed: May 9, 2013
    Publication date: April 30, 2015
    Inventors: Hermona Soreq, Ella Sklan, Shani Shenhar-Tsarfaty, Geula Hanin